SCHEMBL31695362

SCHEMBL31695362

N#Cc1c(-c2ccc(O)c(O)c2)cc(C2CC2)nc1N

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA1 P30542 5/20 0.69
ADORA2A P29274 4/20 0.69
KDM4E B2RXH2 9/20 0.68
HPGD P15428 6/20 0.68
ALDH1A1 P00352 5/20 0.68
MEN1 O00255 4/20 0.68
KMT2A Q03164 4/20 0.68
MAPT P10636 4/20 0.68
NPSR1 Q6W5P4 4/20 0.68
HSD17B10 Q99714 3/20 0.68
TSHR P16473 3/20 0.68
IL4 P05112 1/20 0.64
GAA P10253 1/20 0.56
PIM1 P11309 2/20 0.49
SMN1; SMN2 Q16637 4/20 0.48
ALOX15 P16050 2/20 0.48
TDP1 Q9NUW8 1/20 0.48
MAPK1 P28482 1/20 0.48
CASP1 P29466 1/20 0.48
CASP7 P55210 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31695292 0.95 ADORA1 (0.62) ADORA1ADORA2AKDM4EHPGDALDH1A1
SCHEMBL31695344 0.94 ADORA1 (0.61) ADORA1ADORA2AKDM4EHPGDALDH1A1
SCHEMBL31695327 0.79 KDM4E (0.66) ADORA1ADORA2AKDM4EHPGDALDH1A1
SCHEMBL23833502 0.78 IL4 (1.00) ADORA1ADORA2AKDM4EHPGDALDH1A1
SCHEMBL23833503 0.78 IL4 (1.00) ADORA1ADORA2AKDM4EHPGDALDH1A1
SCHEMBL23841221 0.78 IL4 (0.77) ADORA1ADORA2AKDM4EHPGDALDH1A1
SCHEMBL31695325 0.75 IL4 (0.72) ADORA1ADORA2AKDM4EHPGDALDH1A1
SCHEMBL31695349 0.75 IL4 (0.72) ADORA1ADORA2AKDM4EHPGDALDH1A1
SCHEMBL31695332 0.74 IL4 (0.78) ADORA1ADORA2AKDM4EHPGDALDH1A1
SCHEMBL31695308 0.74 ADORA1 (0.78) ADORA1ADORA2AKDM4EHPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250313530-A1 SMALL MOLECULE INHIBITORS OF INTERLEUKIN-4 AND USES THEREOF TRUSTEES OF BOSTON UNIVERSITY (US) 2025-10-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250313530-A1 SMALL MOLECULE INHIBITORS OF INTERLEUKIN-4 AND USES THEREOF IL4, IRAK4, IL5 ADORA1 3438/4885ADORA2A 3796/4885KDM4E 551/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.